During the last session, XPO Inc (NYSE:XPO)’s traded shares were 0.86 million, with the beta value of the company hitting 2.10. At the end of
During the last session, Pliant Therapeutics Inc (NASDAQ:PLRX)’s traded shares were 0.33 million, with the beta value of the company hitting 1.09. At the end
During the last session, Fabrinet (NYSE:FN)’s traded shares were 0.87 million, with the beta value of the company hitting 0.95. At the end of the
During the last session, Qudian Inc ADR (NYSE:QD)’s traded shares were 0.44 million, with the beta value of the company hitting 0.61. At the end
During the last session, Bio-Key International Inc (NASDAQ:BKYI)’s traded shares were 0.3 million, with the beta value of the company hitting 0.25. At the end
During the last session, ProKidney Corp (NASDAQ:PROK)’s traded shares were 0.39 million, with the beta value of the company hitting 1.31. At the end of
During the last session, Biodesix Inc (NASDAQ:BDSX)’s traded shares were 0.55 million, with the beta value of the company hitting 1.21. At the end of
During the last session, Danimer Scientific Inc (NYSE:DNMR)’s traded shares were 0.71 million, with the beta value of the company hitting 1.63. The 52-week high
During the last session, RELX Plc ADR (NYSE:RELX)’s traded shares were 0.86 million, with the beta value of the company hitting 0.89. At the end
During the last session, Vista Gold Corp (AMEX:VGZ)’s traded shares were 0.49 million, with the beta value of the company hitting 1.73. The 52-week high
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
